CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenues
Product sales	$ 1,851,033	$ 2,362,774	$ 3,274,251	$ 4,615,903
License fees	100,595	0	201,189	0
Royalties	374,476	61,124	696,593	125,296
Total revenues	2,326,104	2,423,898	4,172,033	4,741,199
Cost of revenues
Cost of sales	1,853,047	1,354,705	3,261,868	2,622,015
Cost of royalties	44,446	3,940	88,690	9,074
Total cost of revenues	1,897,493	1,358,645	3,350,558	2,631,089
Gross profit	428,611	1,065,253	821,475	2,110,110
Operating expenses
Salaries and wages	2,587,909	2,045,176	4,269,995	4,043,372
Consulting expenses	333,299	647,117	1,169,631	1,180,629
Professional fees	392,937	316,506	632,029	441,854
Research, development, trials and studies	957,637	1,225,354	1,911,320	2,127,039
General and administrative expenses	1,295,490	1,492,831	2,627,321	3,982,157
Impairment of IPR&D and trademarks	4,683,829	0	4,683,829	0
Total operating expenses	10,251,101	5,726,984	15,294,125	11,775,051
Loss from operations	(9,822,490)	(4,661,731)	(14,472,650)	(9,664,941)
Other income (expense)
Interest, net	(589,703)	(426,284)	(1,768,873)	(945,313)
Change in fair value of derivative liabilities	(902,561)	51,467	(701,499)	244,560
Other	(1,239)	4,788	(1,239)	255
Total other income (expenses)	(1,493,503)	(370,029)	(2,471,611)	(700,498)
Loss before provision for income taxes	(11,315,993)	(5,031,760)	(16,944,261)	(10,365,439)
Income tax provision	4,645	4,890	9,290	9,780
Net loss to common stockholders	$ (11,320,638)	$ (5,036,650)	$ (16,953,551)	$ (10,375,219)
Loss per common share —Basic and diluted (in dollars per share)	$ (0.09)	$ (0.05)	$ (0.15)	$ (0.10)
Weighted average shares outstanding —Basic and diluted (in shares)	121,638,826	104,616,535	116,459,607	101,876,216